Phase II study of irinotecan and amrubicin in patients with relapsed non-small cell lung cancer: Okayama Lung Cancer Study Group Trial 0402

Author: Nogami Naoyuki   Hotta Katsuyuki   Segawa Yoshihiko   Takigawa Nagio   Hosokawa Shinobu   Oze Isao   Fujii Masanori   Ichihara Eiki   Shibayama Takuo   Tada Atsuhiko   Hamada Noboru   Uno Masatoshi   Tamaoki Akihiko   Kuyama Shoichi   Ikeda Genyo   Osawa Masahiro   Takata Saburo   Tabata Masahiro   Tanimoto Mitsune   Kiura Katsuyuki  

Publisher: Informa Healthcare

ISSN: 0284-186X

Source: Acta Oncologica, Vol.51, Iss.6, 2012-07, pp. : 768-773

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content